Keywords: Stada Arzneimittel, Hemofarm, Serbia default, Earnings forecast

Germany’s Stada Arz warns of risk of Serbian default

Article | 22 September 2011

Print This

German drugmaker Stada Arzneimittel (STAGn: DE) has warned that the outstanding receivables due to its Serbian subsidiary Hemofarm AD from ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in